Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Other Equity
Mizuho Medy Co Ltd
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Other Equity
¥1m
|
CAGR 3-Years
900%
|
CAGR 5-Years
298%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Other Equity
¥335.5B
|
CAGR 3-Years
128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Olympus Corp
TSE:7733
|
Other Equity
¥169.6B
|
CAGR 3-Years
159%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Sysmex Corp
TSE:6869
|
Other Equity
¥47.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Other Equity
¥8B
|
CAGR 3-Years
45%
|
CAGR 5-Years
72%
|
CAGR 10-Years
11%
|
|
|
JEOL Ltd
TSE:6951
|
Other Equity
¥5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Other Equity?
Other Equity
1m
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Other Equity amounts to 1m JPY.
What is Mizuho Medy Co Ltd's Other Equity growth rate?
Other Equity CAGR 5Y
298%
The average annual Other Equity growth rates for Mizuho Medy Co Ltd have been 900% over the past three years , 298% over the past five years .
You don't have any saved screeners yet